Share Name Share Symbol Market Type Share ISIN Share Description
Graphene Nano LSE:GRPH London Ordinary Share GB00B9BBJ076 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.23p -3.87% 5.72p 5.50p 5.94p 5.75p 5.60p 5.60p 1,279,527 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 8.0 -34.1 -28.6 - 6.74

Graphene Nano (GRPH) Latest News

More Graphene Nano News
Graphene Nano Takeover Rumours

Graphene Nano (GRPH) Share Charts

1 Year Graphene Nano Chart

1 Year Graphene Nano Chart

1 Month Graphene Nano Chart

1 Month Graphene Nano Chart

Intraday Graphene Nano Chart

Intraday Graphene Nano Chart

Graphene Nano (GRPH) Discussions and Chat

Graphene Nano Forums and Chat

Date Time Title Posts
24/4/201719:23GRAPHENE NANOCHEM: Producing Graphene & Methyl Esters from Renewable Sources7,930.00
28/12/201608:43High possibility to de-list37.00
14/9/200108:45DEAR ADVFN!!!! RE: YOUR NEW GRAPHS2.00

Add a New Thread

Graphene Nano (GRPH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:08:035.6190050.49O
14:55:315.7525,0001,437.50AT
14:55:145.74135,7327,791.02O
14:40:395.7411,394654.02O
14:16:265.45150,0008,175.00O
View all Graphene Nano trades in real-time

Graphene Nano (GRPH) Top Chat Posts

DateSubject
26/4/2017
09:20
Graphene Nano Daily Update: Graphene Nano is listed in the Chemicals sector of the London Stock Exchange with ticker GRPH. The last closing price for Graphene Nano was 5.95p.
Graphene Nano has a 4 week average price of 3.30p and a 12 week average price of 3.30p.
The 1 year high share price is 17.25p while the 1 year low share price is currently 3.30p.
There are currently 117,886,210 shares in issue and the average daily traded volume is 1,322,701 shares. The market capitalisation of Graphene Nano is £6,778,457.08.
11/4/2017
09:01
top tips: If you are interested in graphene look at Modern Water (MWG) who are involved in the graphene project at Manchester Uni and see their Annual Results. www.modernwater.com/assets/downloads/press/170328%20Press%20release%20Masdar%20UoM%20(v_final).pdf MWG looks like a loaded spring if I understand this correctly in the Annual Results..... Monitoring division delivered positive EBITDA. strategy review undertook in 2015 bearing fruit and now in a position where we are working on a variety of new product developments which we believe will add to our portfolio and positively impact sales and profits as we move forward. Revenue and gross profit increased on the prior year, whilst overheads continued to reduce. financial position was debt free, with cash of GBP1.1m Membrane division expected to break even in 2018 trade finance facility secured Group now has the resources in place to become a genuinely sustainable, profitable business. With an un-geared balance sheet, a cash generative Monitoring division, the Membrane division expected to break even in 2018 and a trade finance facility secured, we believe the Group now has the resources in place to become a genuinely sustainable, profitable business. joint venture between Modern Water and Northumbrian Water, where our JV has preferred bidder status and has satisfied all its responsibilities and obligations. ----- So they will be in profit in 2018, continue to grow revenues and there is the added bonus of the chance of the JV with Northumbrian Water on which they are "preferred bidder" getting the go-ahead on the £20m contract for the new Gibralter water treatment plant, no share issues needed because they have a finance facility in place, plus they are involved in the new "cutting edge" graphene research project at Manchester Uni., and Directors have been stakebuilding recently. Share price 9p gives just £7m valuation. MWG were 43p in 2014, 63p in 2013 and 136p in 2007. Must be worth somewhere in that range now.
07/2/2017
19:46
john henry: Death spiral financingDeath spiral financing is a process in which convertible financing used to fund primarily small cap companies can be used against it in the marketplace to cause the company's stock to fall dramatically, which can lead to the company's ultimate downfall.Many small companies rely on selling convertible debt to large private investors (see private investment in public equity) to fund their operations and growth. This convertible debt, often convertible preferred stock or convertible debentures, can be converted to the common stock of the issuing company often at steep discounts to the market value of the common stock. Under the typical "death spiral" scenario, the holder of the convertible debt initially shorts the issuer's common stock, which often causes the stock price to decline, at which time the debt holder converts some of the convertible debt to common shares with which he then covers the debt holder's short position. The debt holder continues to sell short and cover with converted stock, which, along with selling by other shareholders alarmed by the falling price, continually weakens the share price, making the shares unattractive to new investors and possibly severely limiting the company's ability to obtain new financing if necessary.An important characteristic of this kind of convertible debt is that it often carries conditions like a quarterly or semiannual reset of the conversion price to keep the conversion price more or less close to the actual stock price. However, a lower conversion price also increases the number of shares that a bond holder gets in exchange for one bond, which increases the dilution of existing shareholders. A lower price reset can also force investors that have set up a long CB/short stock position to sell more stock ("adjust the delta"), creating a vicious circle, hence the nickname death spiral.Companies willing to agree to financing on these terms are often desperate and could not obtain funding through any other means. The terms, though viewed by some as onerous, give the lender a potential way to recover their debt regardless of what happens to the shares of the company. The lender would have a potentially greater gain if the shares were to increase in value, but if they decrease in value, there is some protection. Otherwise, they would probably not be willing to lend the money because of the poor risk profiles of the companies interested in this type of financing.
30/1/2017
10:51
leedskier: Meanwhile Scomi Energy Services share price has risen from a low of 13 SEN to 20 SEN this year. That seems to be on the back of its anticipated revenue boost from oil production from the JV off the Malaysian coast, which is projected to come on stream in a few months. hTTp://www.thestar.com.my/business/business-news/2017/01/14/scomi-energy-set-for-ophir-boost/ the stronger Scomi Energy Services the better for GRPH.
05/1/2017
18:52
mdvorkin: Seems to be a mix of both good comments and bad. I for one am very pleased that with all the problems the company has been able to relist and therefore stakeholders have the opportunity to either leave or stay. An article issued today on seeking alpha gives a reasonably good update on the current graphene market and is also very positive towards Graphene Nanochem. I've provided the link but also attached the info. http://seekingalpha.com/article/4034525-graphene-investing-2017 Graphene Investing In 2017 Jan. 5, 2017 10:45 AM ET Summary The risks are high especially in mineral mining stocks promoting their intentions to insert themselves in the graphite and graphene nascent industry. Stock picking is a worthless endeavor using traditional fundamental and technical analyses. Investors do grunt work to find companies with which they feel comfortable. Nevertheless, graphene is the most exciting new industry since the digital revolution and there are four companies worthy of investment consideration. High Risks My first background article addressing the wonder chemical graphene for Seeking Alpha cautions investors to the high risks involved: · There are few publicly traded companies. · They are in the R&D stage of development, or in · Mining minerals that carry heavy baggage from governments · Seed stage of developing with unconfirmed products for commercial and healthcare applications, and · Companies are hindered by high costs and first stage technology for producing graphene in mass quantity. Unending Growth Potential Nevertheless, it is the most exciting new industry since the digital revolution. Materials & Chemicals Market Research News just released a report affirming, "We expect that China's graphene market size will grow at a compound annual rate of over 90% in 2016-2020." It also lists more than a dozen companies engaged in mining minerals, R&D, and commercialization of graphene. My biochemist educated son forwards science articles to me practically every day. Articles about graphene awakened me to the ways graphene will change our lives. The potential for graphene commercialization is seemingly unending, a sui generis. Information about new applications of graphene in science publications out in the few short weeks since my article in Seeking Alpha detail applications for graphene having the potential to detect cancer cells, improve 3-D printing, make ammunition and guns more efficient and effective, produce a super-strong silk that conducts electricity, helps other materials handle 1,000 times more current than regular materials, build better, safer and longer lasting lithium ion batteries (demand is growing 20% per year), fuel cells, and nuclear reactors. How to Proceed with Investments Fundamentally sound statistical and technical analyses do not yet apply to any pure graphene companies. Stock picking is a worthless endeavor unless investors do the grunt work. I suggest investors find a company that is: · Led by an experienced business management team, · Sticking with a strong sensible business plan, · Deep pocketed with enough cash secured to carry it out, and · Led by a business management team that complements the R&D people. In my earlier article I addressed three small companies with long term potential for growth and profitability: Haydale Graphene Industries (OTC:HDGHF) Graphene 3D Labs (OTCQB:GPHBF) Applied Graphene Materials (OTCPK:APGMF) Early Birds Here is a brief analysis of several listed in the MCMRNews. The first two exemplify the risky business of graphite mining companies. The third investors ought to seriously investigate commercializes graphene with marketability. Northern Graphite Corp (OTCQX: NGPHF) is a start-up company with no revenues but listing a $10m market cap. More than 5,000 are traded almost daily. This Ottawa, CN based company mines graphite. It cannot control fluctuating world prices on the downside. NGPHF touts the company produces "the highest percentage of large flake material, the best infrastructure, the lowest capital costs and the lowest unit operating costs...the highest margins" in an industry with exponentially growing demand for graphene. The share price 42-weeks high was 47 cents. A share sells today for 20 cents. Insiders hold seven percent of the shares, and institutions hold 1.27% shares. StreetAuthority last May describes the stock as "basically a publicly traded business plan." NGPHF reports a chest of $658,000 down from a $1.5 six months ago. Then company reports securing 100% interest in the Bissett Creek graphite property located in Ontario. A Seeking Alpha contributor suggested in May 2015 that Focus Graphite (OTCQX: FCSMF) was not transparent in its use of money raised from stock sales, nor explains "or how it will create value" in the graphite market. They are still listed with shares at 5 cents down from 22 cents. On December 28, 2016, Critical Metals reported FCSMF raised $212,500 from the sale of 2.125M shares. It too is a mining company producing graphite concentrate. A Stand-Out Company Graphene NanoChem PLC (OTCPK: GRPEF) is a very interesting company selling for 16 cents per share. It is a commercialization company "that designs, formulates, manufactures and markets a range of nano-enhanced solutions, from chemicals to performance materials." GRPEF focuses on the oil and gas sectors: fuel additives, oilfield chemicals, and performance chemicals. Its Advanced Materials Division uses graphene nanomaterials for production of chemical synthesis processes, and uses graphene dispersion to enable application for specific performance uses and product commercialization. The company does not intend to become a market supplier of graphene nanomaterials, but uses the proprietary technology for enhancing strategic partnerships in commercialization initiatives. The company headquarters are in Kuala Lumpur, Malaysia. On December 28, 2016 it was announced Graphene NanoChem won its first order for $360,000 causing shares. The share price spiked from a penny trade to 48 cents. Shares currently nearly touch 16 cents. 4,000 barrels of a smart fluid were sold for use in China to make shale drilling faster and improve environmental and economic qualities in two wells. If successful, GRPEF may be tapped to supply its smart fluid to more than 300 other wells China expects to drill in the near future. It is partnering with Scomi for drilling in Southeast Asia. GRPEF is emerging as one of the most promising publicly traded companies. Management wants to design and commercialize its own products. They are decisively defining their target market, and management has little intention of allowing debt-fueled profligacy. Theirs is a tight business plan demonstrating confidence and determination to build the business in their image and maintain control of their future.
01/9/2016
15:08
leedskier: Somewhat unusually: 1. As you know from personal experience, the CEO replies to abrasive emails. 2. The directors have never awarded options. No director has ever sold a share. See above for purchases. 3. There has never been any dilutive fund raising. Were it possible to say the same of other Aim companies, including many run by English johnnies, Aim might not suffer the reputation it does. It is an error to correlate Aim share prices with company performance. BLVN, which is buying back shares almost daily to underpin it's share price, has a market cap of about its cash in the bank and has decent assets, which seemingly have no value. That is the O&G sector in a nutshell. Of course, in common with every other company in the O&G sector, GRPH was hit hard by the 50% fall in oil prices. But it is attempting to remedy that without washing and rinsing shareholders with dilution.
08/12/2015
10:14
mdvorkin: Being a very illiquid share it is very easy for the few to move the share price with a minimum of sells or buys. My view is that the board are waiting for the Scomi orders before they approach their finance groups for funds in order to deliver the products. Unfortunate for all concerned is where the oil price is today and the fact that the companies that Scomi is working with are probably delaying any decisions. In addition, I believe that the share price has been placed under the 20p mark by the market purely to stop the company from buying shares. If you go back to the 2014 year end results in June, it stated that the company would look towards using something like £6m+ to support the share price. The market immediately took the price down below 20p prior to the AGM. Please, this are purely my take on where we are today. And yes, unfortunately I am still invested and watching the share price fall further today.
22/9/2015
19:31
leedskier: I hope they are attempting to be realistic in current market conditions. The last thing we want is for the company to beat the drum and then under deliver. wskill drew attention to PURE this morning, which the CEO and FD of GRPH were founder directors of and which is now intending to move to the main market. For those not involved with GRPH, who has ever heard of it? It achieved its stunning share price prior to the crash and being food it has weathered much of the storm since, but from a PR point of view, it is very, very quiet. It is the same with many Aim pharma companies too. I think it is a mistake to think that lots of public acclamation and BB noise means a higher share price. It may mean more volatility and if ADVFN is any guide it includes sharp moves to the downside. Which is why I am very happy that this BB is now so quiet. I think we have to be patient and see if GRPH can achieve escape velocity as a company and if it does, its share price will follow. The most important thing, for me, is that having spent lots of money on R&D (and generally I think) to create GRPH and the Platdrill series, it now needs to reduce its CAPEX and expenditure, until the storm passes and try and demonstrate that, like Scomi, it can make Net profits, whatever the market conditions. The European and US financial crisis and the austerity in its wake, rather passed the oil producing Middle East and Asian economies by. I guess the good times in Malaysia just kept on keeping on. An example being that the Malaysian Stock Market was the most successful in Asia until the oil price started falling last summer. So for CEO's and directors of Malaysian based companies, I guess the need to reign in expenditure post 2008, never really arose until this year. The banks there seemed more than happy to keep lending and the Government more than happy to keep spending. Now Malaysia is facing a reality check both economically and politically. This is why Scomi was at pains at its recent AGM to make plain that most of its (and GRPH's) revenue is in USD and comes from outside Malaysia.
12/4/2015
13:53
plunger2: I see we've been squabbling again; probably reflecting deep seated grumpiness at the GRPH share price. I still say PGs are of no value to GRPH. They may be officially present but they certainly seem to be unofficially absent. Also they have many dogs in their stable besides this one. Could we do any worse without them? As to the City, the total sloppiness around AiM is ample evidence of its slide. AiM is dying on its feet and nothing happens. I hope I have the sense to never put anything other than token money near it again - EVER EVER EVER! JMHO
04/9/2014
12:16
earnestwipplethwaiteiii: That's fine, but I'd prefer to focus on the "...substantial increases...from 2015". A functional stock market, as we all know, should be a leading indicator of future prospects - typically looking six months ahead. However, this being AIM, and therefore dysfunctional, one can of course not rely on such cosy nostrums. In a just world, now would mark the start of a sustained recovery in the GRPH share price, assuming the company's projections to be accurate.
19/8/2014
18:38
cnx: GRPH share price being influenced by general market only
Graphene Nano share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170426 15:50:58